A detailed history of First Turn Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, First Turn Management, LLC holds 254,800 shares of ITCI stock, worth $23.1 Million. This represents 2.95% of its overall portfolio holdings.

Number of Shares
254,800
Previous 347,343 26.64%
Holding current value
$23.1 Million
Previous $23.8 Billion 21.63%
% of portfolio
2.95%
Previous 3.87%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$67.99 - $80.84 $6.29 Million - $7.48 Million
-92,543 Reduced 26.64%
254,800 $18.6 Billion
Q2 2024

Aug 07, 2024

BUY
$64.76 - $79.84 $9.11 Million - $11.2 Million
140,636 Added 68.04%
347,343 $23.8 Billion
Q1 2024

May 03, 2024

SELL
$64.37 - $75.65 $689,917 - $810,816
-10,718 Reduced 4.93%
206,707 $14.3 Billion
Q4 2023

Feb 07, 2024

BUY
$46.37 - $73.65 $10.1 Million - $16 Million
217,425 New
217,425 $15.6 Billion

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.54B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track First Turn Management, LLC Portfolio

Follow First Turn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Turn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Turn Management, LLC with notifications on news.